Patient-reported outcomes from the United States clinical trial for a hybrid cochlear implant
Otology & Neurotology Sep 21, 2017
Kelsall DC, et al. - This study dealt with the scrutiny of the patient-reported outcomes (PROs) in subjects with significant residual low-frequency hearing and severe-to-profound high-frequency sensorineural hearing loss (SNHL) who received the hybrid cochlear implant (CI). Marked PRO benefits were illustrated on the spatial and qualities of hearing scale (SSQ), device use questionnaire (DUQ) after 6 and 12 months of CI use by the patients who received the hybrid CI. Owing to the opportunity to maintain beneficial low-frequency acoustic hearing, patients retained music listening abilities, as determined by the University of Washington Clinical Assessment of Music Perception (UW-CAMP).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries